Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for antiretroviral treatment (ART) access and success, as emphasized by the 2010 revised WHO ...
Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results